Norges Bank Talis Biomedical Corp Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$6.02 - $12.46 $60,199 - $124,600	-10,000 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$9.62 - $14.56 $96,199 - $145,600	10,000 New	10,000 $110,000
Q2 2021 Aug 10, 2021	SELL	$9.62 - $14.56 $96,199 - $145,600	-10,000 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$11.2 - $27.8 $112,000 - $278,000	10,000 New	10,000 $129,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.